V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20111191 | 20175691 | 1.76 | 74.7 | 03 | null | 2021-05-08 | Sunitinib | 02 | N | SUNITINIB | 100997276 |
| 20111387 | 20175692 | 1.68 | 40 | null | 2018-11-20 | 2021-07-19 | CARBOPLATIN + PACLITAXEL + RT | 2 | null | CARBOPLATIN + PACLITAXEL + RT | 101824299 |
| 20112298 | 20175693 | 1.6 | 75 | Palliative (P) | 2013-12-07 | 2016-07-21 | LUTETIUM-177 | 02 | N | CAPECITABINE + CISPLATIN + RT | 101600163 |
| 20112682 | 20175694 | 1.82 | 78 | Curative (C) | 2020-04-23 | 2020-04-26 | null | 02 | N | LENALIDOMIDE | 100909926 |
| 20112751 | 20175695 | null | 87.4 | Palliative (P) | null | 2022-01-15 | null | 02 | N | BEVACIZUMAB | 101260811 |
| 20113281 | 20175696 | 1.59 | 66.4 | null | null | 2020-07-09 | null | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101332264 |
| 20113533 | 20175697 | 1.68 | 105.3 | null | 2020-01-03 | 2020-01-11 | null | 02 | null | OXALIPLATIN | 100225808 |
| 20114769 | 20175698 | 1.51 | 70 | null | null | 2022-03-26 | null | null | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101262332 |
| 20115021 | 20175699 | 1.8 | 67.4 | Palliative (P) | 2022-04-25 | 2022-05-05 | null | 02 | N | CARBOPLATIN + FLUOROURACIL | 100795971 |
| 20115685 | 20175700 | 1.79 | 92 | Palliative (P) | 2019-06-10 | 2019-06-21 | null | 02 | N | TRIFLURIDINE + TIPIRACIL | 100099316 |
| 20117132 | 20175701 | 1.7 | 75.4 | Palliative (P) | 2018-07-13 | 2018-07-17 | null | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101176873 |
| 20117727 | 20175703 | 1.62 | 42.6 | null | 2019-12-26 | 2021-01-06 | null | 02 | null | MITOMYCIN INTRAVESICULAR | 100676526 |
| 20119819 | 20175704 | 1.68 | 57.5 | Palliative (P) | null | 2018-08-25 | null | 01 | N | LENALIDOMIDE | 100531834 |
| 20119905 | 20175705 | 1.76 | 67 | null | 2018-09-15 | 2018-09-26 | null | 02 | null | MITOMYCIN INTRAVESICULAR | 101806113 |
| 20120501 | 20175706 | 1.6 | 0 | Palliative (P) | 2020-08-02 | 2021-12-24 | Everolimus 10mg | 02 | N | EVEROLIMUS | 101597204 |
| 20121424 | 20175707 | null | 77.4 | Palliative (P) | 2020-02-15 | 2020-06-11 | null | 02 | N | CAPECITABINE + CISPLATIN + RT | 100191559 |
| 20121595 | 20175708 | 1.79 | 47.8 | null | 2019-01-19 | 2019-01-19 | LUTETIUM-177 | N | null | TRIFLURIDINE + TIPIRACIL | 100428743 |
| 20122584 | 20175711 | 1.76 | 92.6 | Neo-adjuvant (N) | 2019-11-04 | 2020-04-10 | null | 02 | Y | ABIRATERONE | 100795329 |
| 20122862 | 20175712 | 1.49 | null | Palliative (P) | 2019-08-10 | 2019-08-10 | null | 02 | null | CAPECITABINE + CISPLATIN + RT | 101168979 |
| 20122938 | 20175713 | 1.73 | 78 | null | 2021-09-08 | 2021-09-13 | null | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100259335 |
| 20123140 | 20175714 | 1.61 | 79.8 | Palliative (P) | 2019-03-15 | 2019-04-19 | null | 02 | N | PEMBROLIZUMAB | 101760433 |
| 20123916 | 20175716 | null | 76 | Palliative (P) | 2017-01-22 | 2017-01-29 | Docetaxel + nintedanib | 02 | N | CAPECITABINE + IRINOTECAN + PANITUMUMAB | 100148757 |
| 20124005 | 20175717 | 1.86 | null | Palliative (P) | 2020-08-31 | 2021-02-20 | CAV | N | null | SCOPE2 TRIAL | 101570061 |
| 20124067 | 20175718 | 1.75 | 47.2 | Curative (C) | 2020-02-15 | 2020-09-22 | Rituximab | 01 | null | TOPOTECAN | 100017932 |
| 20124470 | 20175719 | 1.9 | 70 | Palliative (P) | 2021-04-10 | 2021-04-11 | CHOP R | N | null | DARATUMUMAB | 100368605 |
| 20124526 | 20175720 | 1.62 | 63.7 | Palliative (P) | 2020-03-07 | 2020-03-08 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100138254 |
| 20125058 | 20175721 | 1.62 | 63.7 | Palliative (P) | 2020-09-21 | 2020-09-21 | Bendamustine + Obinutuzumab | 2 | null | BORTEZOMIB + DARATUMUMAB | 101523786 |
| 20125986 | 20175722 | 1.77 | 96 | Curative (C) | 2021-05-04 | 2021-05-04 | Gemcitabine + Oxaliplatin | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100261119 |
| 20127387 | 20175725 | 1.51 | 40.4 | 03 | 2020-10-16 | 2020-10-29 | Bortezomib + Daratumumab | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100568877 |
| 20128425 | 20175727 | 1.69 | 68.6 | null | 2021-02-12 | 2021-02-12 | FOXTROT TRIAL | 02 | N | CARBOPLATIN + PEMETREXED | 101186030 |
| 20128598 | 20175728 | 1.6 | 105 | Disease modification (D) | 2021-06-16 | 2021-06-16 | Hydroxycarbamide | 02 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 100656961 |
| 20128711 | 20175729 | 1.75 | 51.1 | Palliative (P) | 2021-12-22 | 2022-01-06 | IBRUTINIB | 02 | N | POMALIDOMIDE | 101513469 |
| 20128758 | 20175730 | 1.61 | 53.4 | Palliative (P) | 2022-02-16 | 2022-03-06 | Bevacizumab + Irinotecan + MdG | 02 | N | HYDROXYCARBAMIDE | 100056430 |
| 20130428 | 20175733 | 1.84 | null | null | null | 2022-02-12 | ARISTOTLE TRIAL | null | N | CAPECITABINE + STREPTOZOCIN | 100859039 |
| 20130468 | 20175734 | 1.74 | 71.9 | Palliative (P) | 2018-05-04 | 2018-05-12 | NAB PACLITAXEL | 02 | Y | TRABECTEDIN | 101289378 |
| 20130762 | 20175735 | null | 36 | Palliative (P) | 2017-09-13 | 2017-09-13 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 2 | N | ECF | 100789923 |
| 20131500 | 20175736 | 1.62 | 69 | null | 2020-06-28 | 2020-07-02 | null | 02 | N | CAPECITABINE + STREPTOZOCIN | 100071965 |
| 20131694 | 20175737 | 1.9 | 91 | null | 2021-09-15 | 2021-09-29 | DARATUMUMAB | 02 | N | POMALIDOMIDE | 101227084 |
| 20131904 | 20175739 | 0 | null | Curative (C) | 2021-11-22 | 2021-11-28 | Hydroxycarbamide | 01 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100112547 |
| 20131959 | 20175740 | 1.81 | 70.4 | null | 2015-09-25 | 2019-06-23 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | null | LIPOSOMAL DAUNORUBICIN + LIPOSOMAL CYTARABINE (VYXEOS) | 101090541 |
| 20132270 | 20175741 | 1.77 | 57 | 03 | 2021-11-29 | 2021-12-04 | Hepatoblastoma VHR Block A Cisplatin/Dox | 02 | N | MITOMYCIN | 101458958 |
| 20132504 | 20175742 | 1.69 | 9.2 | null | 2020-01-04 | 2020-01-04 | null | 02 | null | OXALIPLATIN + MDG + PANITUMUMAB | 101336593 |
| 20132615 | 20175743 | 1.85 | 14.8 | null | 2021-09-01 | 2021-09-04 | Trametinib | N | N | AZACITIDINE | 101410148 |
| 20132689 | 20175744 | 1.85 | 74.8 | null | 2017-09-26 | 2018-05-20 | Bevacizumab + FLUOROURACIL + IRINOTECAN | 02 | N | BEVACIZUMAB + CAPE + OXALIPLATIN | 100298501 |
| 20133073 | 20175745 | 1.57 | 65.7 | Palliative (P) | 2016-01-04 | 2016-12-01 | RUXOLITINIB | 02 | null | CISPLATIN + FLUOROURACIL + RT | 100460249 |
| 20133526 | 20175746 | 1.75 | 45 | Neo-adjuvant (N) | null | 2021-04-07 | TCH (21 day Trastuzumab) Loading | N | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101369305 |
| 20134721 | 20175747 | 1.65 | 94.7 | Palliative (P) | 2019-07-01 | 2019-07-01 | Cisplatin + Fluorouracil + RT 5day | 02 | null | GEFITINIB | 100284389 |
| 20134872 | 20175748 | 1.61 | 53.2 | Palliative (P) | 2016-07-09 | 2016-07-09 | Gemcitabine + Oxaliplatin | 02 | N | NEO-AEGIS TRIAL | 101696186 |
| 20137533 | 20175751 | 1.8 | 70.85 | null | 2020-08-10 | 2020-09-09 | ACTICCA-1 Trial | 02 | null | FOCUS4 TRIAL | 101488838 |
| 20139686 | 20175752 | 1.85 | 63.6 | Adjuvant (A) | null | 2016-10-27 | CHOP R - 21 days | 02 | N | HYDROXYCARBAMIDE | 100253851 |